Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of AMD3100 as a Sensitizing Agent in Myeloablative Allogeneic Blood and Marrow Transplantation for Chemotherapy Resistant Pediatric Acute Leukemia

NCT01655875 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT01655875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01655875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of AMD3100 as a Sensitizing Agent in Myeloablative Allogeneic Blood and Marrow Transplantation for Chemotherapy Resistant Pediatric Acute Leukemia
Lead sponsor
Emory University
Phase
Phase 1
Overall status
Terminated
Start date
June 30, 2012
Completion date
April 30, 2014
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pediatric acute lymphoblastic leukemia, relapsed, pediatric acute myeloblastic leukemia, relapsed